Raphael Pharmaceutical Inc.
RAPH
Rank in Stocks
#24796
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Share Price
$1.51
Last synced: 2026-11-06
Market Cap
$30.47M
Change (1 day)
0.00%
Change (1 year)
51.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Raphael Pharmaceutical Inc. (RAPH)
Category
Healthcare
P/B ratio for Raphael Pharmaceutical Inc. (RAPH)
P/B ratio as of November 2026 TTM: -16.16
According to Raphael Pharmaceutical Inc.'s latest financial reports and stock price, its current price-to-book ratio (TTM) is -16.16. At the end of 2025 the company had a P/B ratio of -19.10.
P/B ratio history for Raphael Pharmaceutical Inc. from 2021 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | -16.16 | -15.38% |
| 2025 | -19.10 | 191.92% |
| 2024 | -6.54 | -104.19% |
| 2023 | 156.23 | -47.51% |
| 2022 | 297.65 | 11.84% |
| 2021 | 266.13 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 1.9866 | -112.29% |
DE
|
|
| 2.1802 | -113.49% |
DE
|
|
| 1.4014 | -108.67% |
JP
|
|
| 6.6316 | -141.03% |
CH
|
|
| 6.1291 | -137.92% |
IL
|
Questions about Raphael Pharmaceutical Inc.'s P/B ratio
What is Raphael Pharmaceutical Inc.'s P/B ratio?
Raphael Pharmaceutical Inc.'s P/B ratio is -16.16, as of Nov 2026.
What was Raphael Pharmaceutical Inc.'s P/B ratio in 2025?
In 2025, Raphael Pharmaceutical Inc.'s P/B ratio was -19.10, compared with -6.54 in 2024.
How has Raphael Pharmaceutical Inc.'s P/B ratio changed since 2021?
From 2021 to 2025, Raphael Pharmaceutical Inc.'s P/B ratio was highest in 2022 (297.65) and lowest in 2025 (-19.10).
How does Raphael Pharmaceutical Inc.'s P/B ratio compare with similar companies?
Raphael Pharmaceutical Inc.'s P/B ratio (-16.16) is lower than that of all 5 similar companies listed above. The highest among them is Galderma Group AG, with 6.63.